US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist

2.815
-0.029-1.03%

Close May 16 16:00 ET

23.39MMarket Cap-1144P/E (TTM)

Lisata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-3.55%6.6M

-55.37%25.71M

-7.87%6.03M

-84.19%5.96M

2.31%6.88M

3.38%6.84M

98.28%57.6M

-4.51%6.54M

441.33%37.72M

-5.97%6.72M

Selling and administrative expenses

-8.32%3.36M

-8.25%12.97M

-9.44%3.01M

-35.27%2.58M

6.51%3.71M

9.83%3.67M

23.24%14.14M

18.66%3.33M

40.42%3.99M

23.70%3.49M

-General and administrative expense

-8.32%3.36M

-8.25%12.97M

-9.44%3.01M

-35.27%2.58M

6.51%3.71M

--3.67M

23.24%14.14M

18.66%3.33M

40.42%3.99M

23.70%3.49M

Research and development costs

1.95%3.24M

-70.70%12.73M

-6.25%3.01M

-89.98%3.38M

-2.23%3.16M

-3.17%3.18M

147.27%43.46M

-20.56%3.21M

717.65%33.73M

-25.29%3.23M

Operating profit

3.55%-6.6M

55.37%-25.71M

7.87%-6.03M

84.19%-5.96M

-2.31%-6.88M

-3.38%-6.84M

-98.28%-57.6M

4.51%-6.54M

-441.33%-37.72M

5.97%-6.72M

Net non-operating interest income expense

Other net income (expense)

-38.81%402K

182.94%2.54M

20.00%660K

108.61%703K

451.06%518K

872.94%657K

1,080.26%897K

900.00%550K

721.95%337K

318.60%94K

Gain on sale of security

-12.09%589K

158.94%2.72M

20.68%671K

111.87%714K

610.64%668K

963.49%670K

596.69%1.05M

1,290.00%556K

721.95%337K

100.00%94K

Other non- operating income (expenses)

-1,338.46%-187K

-20.00%-186K

-83.33%-11K

---11K

---150K

91.22%-13K

-106.67%-155K

-140.00%-6K

----

Income before tax

-0.19%-6.2M

59.14%-23.17M

10.43%-5.37M

85.93%-5.26M

4.06%-6.36M

7.73%-6.19M

-95.71%-56.7M

11.83%-5.99M

-439.67%-37.38M

7.84%-6.63M

Income tax

-798K

6.01%-2.33M

-2.33M

-64.39%-2.48M

Net income

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

-439.67%-37.38M

-16.61%-6.63M

Net income continuous Operations

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

-439.67%-37.38M

-16.61%-6.63M

Minority interest income

Net income attributable to the parent company

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

-439.67%-37.38M

-16.61%-6.63M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

-439.67%-37.38M

-16.61%-6.63M

Basic earnings per share

15.58%-0.65

75.36%-2.58

12.95%-0.66

91.75%-0.65

69.51%-0.5

26.67%-0.77

-40.54%-10.47

55.13%-0.7582

-352.87%-7.88

-9.33%-1.64

Diluted earnings per share

15.58%-0.65

75.36%-2.58

12.95%-0.66

91.75%-0.65

69.51%-0.5

26.67%-0.77

-40.54%-10.47

55.13%-0.7582

-352.87%-7.88

-9.33%-1.64

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-3.55%6.6M	-55.37%25.71M	-7.87%6.03M	-84.19%5.96M	2.31%6.88M	3.38%6.84M	98.28%57.6M	-4.51%6.54M	441.33%37.72M	-5.97%6.72M
Selling and administrative expenses	-8.32%3.36M	-8.25%12.97M	-9.44%3.01M	-35.27%2.58M	6.51%3.71M	9.83%3.67M	23.24%14.14M	18.66%3.33M	40.42%3.99M	23.70%3.49M
-General and administrative expense	-8.32%3.36M	-8.25%12.97M	-9.44%3.01M	-35.27%2.58M	6.51%3.71M	--3.67M	23.24%14.14M	18.66%3.33M	40.42%3.99M	23.70%3.49M
Research and development costs	1.95%3.24M	-70.70%12.73M	-6.25%3.01M	-89.98%3.38M	-2.23%3.16M	-3.17%3.18M	147.27%43.46M	-20.56%3.21M	717.65%33.73M	-25.29%3.23M
Operating profit	3.55%-6.6M	55.37%-25.71M	7.87%-6.03M	84.19%-5.96M	-2.31%-6.88M	-3.38%-6.84M	-98.28%-57.6M	4.51%-6.54M	-441.33%-37.72M	5.97%-6.72M
Net non-operating interest income expense
Other net income (expense)	-38.81%402K	182.94%2.54M	20.00%660K	108.61%703K	451.06%518K	872.94%657K	1,080.26%897K	900.00%550K	721.95%337K	318.60%94K
Gain on sale of security	-12.09%589K	158.94%2.72M	20.68%671K	111.87%714K	610.64%668K	963.49%670K	596.69%1.05M	1,290.00%556K	721.95%337K	100.00%94K
Other non- operating income (expenses)	-1,338.46%-187K	-20.00%-186K	-83.33%-11K	---11K	---150K	91.22%-13K	-106.67%-155K	-140.00%-6K	----	----
Income before tax	-0.19%-6.2M	59.14%-23.17M	10.43%-5.37M	85.93%-5.26M	4.06%-6.36M	7.73%-6.19M	-95.71%-56.7M	11.83%-5.99M	-439.67%-37.38M	7.84%-6.63M
Income tax	-798K	6.01%-2.33M	0	0	-2.33M	0	-64.39%-2.48M	0	0	0
Net income	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M	-439.67%-37.38M	-16.61%-6.63M
Net income continuous Operations	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M	-439.67%-37.38M	-16.61%-6.63M
Minority interest income	0	0	0	0	0	0	0	0	0	0
Net income attributable to the parent company	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M	-439.67%-37.38M	-16.61%-6.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M	-439.67%-37.38M	-16.61%-6.63M
Basic earnings per share	15.58%-0.65	75.36%-2.58	12.95%-0.66	91.75%-0.65	69.51%-0.5	26.67%-0.77	-40.54%-10.47	55.13%-0.7582	-352.87%-7.88	-9.33%-1.64
Diluted earnings per share	15.58%-0.65	75.36%-2.58	12.95%-0.66	91.75%-0.65	69.51%-0.5	26.67%-0.77	-40.54%-10.47	55.13%-0.7582	-352.87%-7.88	-9.33%-1.64
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall